127
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Evaluation of the MeltPro Myco Assay for the Identification of Non-Tuberculous Mycobacteria

ORCID Icon, , , &
Pages 3287-3293 | Published online: 22 Jun 2022

References

  • Falkinham JO 3rd. Environmental sources of nontuberculous mycobacteria. Clin Chest Med. 2015;36(1):35–41. doi:10.1016/j.ccm.2014.10.003
  • Forbes BA, Hall GS, Miller MB, et al. Practical guidance for clinical microbiology laboratories: mycobacteria. Clin Microbiol Rev. 2018;31(2):e00038–17. doi:10.1128/CMR.00038-17
  • Larsson LO, Polverino E, Hoefsloot W, et al. Pulmonary disease by non-tuberculous mycobacteria - clinical management, unmet needs and future perspectives. Expert Rev Respir Med. 2017;11(12):977–989. doi:10.1080/17476348.2017.1386563
  • Kobayashi T, Nishijima T, Teruya K, et al. High mortality of disseminated non-tuberculous mycobacterial infection in HIV-infected patients in the antiretroviral therapy era. PLoS One. 2016;11(3):e0151682. doi:10.1371/journal.pone.0151682
  • Varley CD, Ku JH, Henkle E, Schafer SD, Winthrop KL. Disseminated nontuberculous mycobacteria in HIV-infected patients, Oregon, USA, 2007–2012. Emerg Infect Dis. 2017;23(3):533–535. doi:10.3201/eid2303.161708
  • Zhang ZX, Cherng BPZ, Sng LH, Tan YE. Clinical and microbiological characteristics of non-tuberculous mycobacteria diseases in Singapore with a focus on pulmonary disease, 2012–2016. BMC Infect Dis. 2019;19(1):436. doi:10.1186/s12879-019-3909-3
  • Marras TK, Chedore P, Ying AM, Jamieson F. Isolation prevalence of pulmonary non-tuberculous mycobacteria in Ontario, 1997–2003. Thorax. 2007;62(8):661–666.
  • Billinger ME, Olivier KN, Viboud C, et al. Nontuberculous mycobacteria-associated lung disease in hospitalized persons, United States, 1998–2005. Emerg Infect Dis. 2009;15(10):1562–1569. doi:10.3201/eid1510.090196
  • Sood G, Parrish N. Outbreaks of nontuberculous mycobacteria. Curr Opin Infect Dis. 2017;30(4):404–409. doi:10.1097/QCO.0000000000000386
  • Prevots DR, Marras TK. Epidemiology of human pulmonary infection with nontuberculous mycobacteria: a review. Clin Chest Med. 2015;36(1):13–34. doi:10.1016/j.ccm.2014.10.002
  • Donohue MJ, Wymer L. Increasing prevalence rate of nontuberculous mycobacteria infections in five states, 2008–2013. Ann Am Thorac Soc. 2016;13(12):2143–2150. doi:10.1513/AnnalsATS.201605-353OC
  • Yu X, Liu P, Liu G, et al. The prevalence of non-tuberculous mycobacterial infections in mainland China: systematic review and meta-analysis. J Infect. 2016;73(6):558–567. doi:10.1016/j.jinf.2016.08.020
  • Damaraju D, Jamieson F, Chedore P, Marras TK. Isolation of non-tuberculous mycobacteria among patients with pulmonary tuberculosis in Ontario, Canada. Int J Tuberc Lung Dis. 2013;17(5):676–681. doi:10.5588/ijtld.12.0684
  • Chien JY, Lai CC, Sheng WH, Yu CJ, Hsueh PR. Pulmonary infection and colonization with nontuberculous mycobacteria, Taiwan, 2000–2012. Emerg Infect Dis. 2014;20(8):1382–1385. doi:10.3201/eid2008.131673
  • Griffith DE, Aksamit T, Brown-Elliott BA, et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med. 2007;175(4):367–416. doi:10.1164/rccm.200604-571ST
  • Nie W, Duan H, Huang H, Lu Y, Chu N. Species identification and clarithromycin susceptibility testing of 278 clinical nontuberculosis mycobacteria isolates. Biomed Res Int. 2015;2015:506598. doi:10.1155/2015/506598
  • Wang X, Li H, Jiang G, et al. Prevalence and drug resistance of nontuberculous mycobacteria, northern China, 2008–2011. Emerg Infect Dis. 2014;20(7):1252–1253. doi:10.3201/eid2007.131801
  • Pang Y, Tan Y, Chen J, et al. Diversity of nontuberculous mycobacteria in eastern and southern China: a cross-sectional study. Eur Respir J. 2017;49(3):1601429. doi:10.1183/13993003.01429-2016
  • Liu H, Lian L, Jiang Y, et al. Identification of species of nontuberculous mycobacteria clinical isolates from 8 provinces of China. Biomed Res Int. 2016;2016:2153910. doi:10.1155/2016/2153910
  • Tan Y, Su B, Shu W, et al. Epidemiology of pulmonary disease due to nontuberculous mycobacteria in Southern China, 2013–2016. BMC Pulm Med. 2018;18(1):168. doi:10.1186/s12890-018-0728-z
  • Russo C, Tortoli E, Menichella D. Evaluation of the new Genotype Mycobacterium assay for identification of mycobacterial species. J Clin Microbiol. 2006;44(2):334–339. doi:10.1128/JCM.44.2.334-339.2006
  • Mäkinen J, Marjamäki M, Marttila H, Soini H. Evaluation of a novel strip test, Genotype Mycobacterium CM/AS, for species identification of mycobacterial cultures. Clin Microbiol Infect. 2006;12(5):481–483. doi:10.1111/j.1469-0691.2006.01380.x
  • Gitti Z, Neonakis I, Fanti G, Kontos F, Maraki S, Tselentis Y. Use of the GenoType Mycobacterium CM and AS assays to analyze 76 nontuberculous mycobacterial isolates from Greece. J Clin Microbiol. 2006;44(6):2244–2246. doi:10.1128/JCM.02088-05
  • Xu Y, Liang B, Du C, et al. Rapid identification of clinically relevant mycobacterium species by multicolor melting curve analysis. J Clin Microbiol. 2019;57(1):e01096–18. doi:10.1128/JCM.01096-18
  • Singh AK, Maurya AK, Umrao J, et al. Role of GenoType(®) Mycobacterium common mycobacteria/additional species assay for rapid differentiation between mycobacterium tuberculosis complex and different species of non-tuberculous mycobacteria. J Lab Physicians. 2013;5(2):83–89. doi:10.4103/0974-2727.119847
  • Dastranj M, Farahani A, Hashemi Shahraki A, et al. Molecular identification and distribution of non-tuberculous mycobacteria isolated from clinical specimens by PCR-sequencing method in West of Iran. Clin Respir J. 2018;12(3):996–1002. doi:10.1111/crj.12617
  • Mohajeri P, Yazdani L, Shahraki AH, et al. Verification of frequency in species of nontuberculous mycobacteria in Kermanshah drinking water supplies using the PCR-sequencing method. Microb Drug Resist. 2017;23(3):359–364. doi:10.1089/mdr.2016.0064
  • Khosravi AD, Mirsaeidi M, Farahani A, et al. Prevalence of nontuberculous mycobacteria and high efficacy of d-cycloserine and its synergistic effect with clarithromycin against mycobacterium fortuitum and mycobacterium abscessus. Infect Drug Resist. 2018;11:2521–2532. doi:10.2147/IDR.S187554